Depsipeptide in Treating Patients With Solid Tumors

NCT00019318 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: romidepsin

Sponsor

National Cancer Institute (NCI)